Print
Email
Print Edition StoriesTuesday, December 22, 2009
Court rules against Hologic patent infringement claim
By Mass High Tech staff
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
MHT's Galen Moore: Six Mass. tech firms head to world economic forum
MHT's Julie Donnelly: Life science startups finding investments
Hologic Inc., a Bedford-based women’s medical diagnostics, imaging and surgical products firm, lost a patent infringement suit the company brought against SenoRx Inc. in the U.S. District Court for the Northern District of California.
The law suit was filed by Hologic, its Marlborough subsidiary Cytyc Corp. and Hologic LP Inc., alleging two claims of patent infringement on its brachytherapy technology, a form of radiation treatment where radioactive “seeds” are placed in cancerous tissue. The jury found neither claim to be valid.
Hologic officials said they plan to appeal the decision, noting, “We believe the decision was based in part on an incorrect claim construction,” according to Mark Casey, Hologic senior vice president and general counsel.
Hologic (Nasdaq: HOLX) first filed the lawsuit against its California-based competitor in January of 2008.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
